Get the app!
Back to Trades
Other4

IGM Biosciences, Inc.

IGMS

Total Value
$0

Company Information

Ticker Symbol
IGMS
CIK
0001496323

Insider Information

Role
Insider
Location
MOUNTAIN VIEW, CA

Filing Details

Filing Date
Aug 14, 2025
Transaction Date
Aug 14, 2025
Accession Number
0001415889-25-021950
Form Type
4

Non-Derivative Transactions

DateSecuritySharesPriceTypeValue
Aug 14, 2025Common Stock22,222Disposition
Aug 14, 2025Common Stock330,700Disposition
Aug 14, 2025Common Stock29,807Disposition
Aug 14, 2025Common Stock29,806Disposition

Footnotes

  1. (F1)Pursuant to the Agreement and Plan of Merger dated July 1, 2025, by and among IGM Biosciences, Inc. (the "Company"), Concentra Biosciences, LLC, a Delaware limited liability company ("Parent"), and Concentra Merger Sub V, Inc., a Delaware corporation and a wholly owned subsidiary of Parent ("Merger Sub"), on August 14, 2025, Merger Sub merged with and into the Company (the "Merger"), with the Company continuing as the surviving corporation and a wholly owned subsidiary of Parent. In connection with the Merger, each issued and outstanding share of the Company's Common Stock was cancelled and converted into the right to receive (i) an amount equal to $1.247 in cash and (ii) one contractual contingent value right (a "CVR") subject to the terms and conditions of a Contingent Value Rights Agreement.
  2. (F2)Prior to the Merger, the shares were held in the name of KBW 2005 Trust for which Reporting Person is the Trustee.
  3. (F3)Prior to the Merger, the shares were held in the name of Non-Exempt Trust for Patrick R. Wilsey Under the Alfred S. Wilsey, Jr. Revocable Trust for which Reporting Person is a Trustee.
  4. (F4)Prior to the Merger, the shares were held in the name of Non-Exempt Trust for Shannon K. Wilsey Under the Alfred S. Wilsey, Jr. Revocable Trust for which Reporting Person is a Trustee.

SEC Filing

View on SEC Daily

View the complete filing document on SEC Daily.